Profiel
Robert Letellier founded PharmaGap, Inc. in 1999, where he worked as Director from 2010 to 2012 and AB Biotech, Inc. in 2004, where he is working as President, Chief Executive Officer & Director from 2011.
Mr. Letellier received his undergraduate degree from the University of Sherbrooke.
Actieve functies van Robert Letellier
| Bedrijven | Functie | Begin |
|---|---|---|
AB Biotech, Inc.
 AB Biotech, Inc. Pharmaceuticals: MajorHealth Technology AB Biotech, Inc. develops and commercializes immunological products. It also develops an immunological approach to sexing semen for all species and humans. The company was founded by Robert Letellier in 2004 and is headquartered in Montréal, Canada. | Oprichter | 21-10-2010 |
Eerdere bekende functies van Robert Letellier
| Bedrijven | Functie | Einde |
|---|---|---|
PharmaGap, Inc.
 PharmaGap, Inc. BiotechnologyHealth Technology PharmaGap, Inc. engages in developing novel peptide therapeutics for the treatment of cancer. The company was founded by Robert Letellier, Jenny Phipps and Michel Phipps on October 6, 1999 and is headquartered in Ottawa, Canada. | Oprichter | - |
Opleiding van Robert Letellier
| University of Sherbrooke | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
PharmaGap, Inc.
PharmaGap, Inc. BiotechnologyHealth Technology PharmaGap, Inc. engages in developing novel peptide therapeutics for the treatment of cancer. The company was founded by Robert Letellier, Jenny Phipps and Michel Phipps on October 6, 1999 and is headquartered in Ottawa, Canada. | Health Technology |
AB Biotech, Inc.
AB Biotech, Inc. Pharmaceuticals: MajorHealth Technology AB Biotech, Inc. develops and commercializes immunological products. It also develops an immunological approach to sexing semen for all species and humans. The company was founded by Robert Letellier in 2004 and is headquartered in Montréal, Canada. | Health Technology |
